Cargando…
Challenging the paradigm
While advocating for addressing “treatable traits” is admirable in that it reminds clinicians to consider the patient and not the disease, the use of this idea to promote dangerous changes in practice should be challenged. https://bit.ly/30VkP8Q
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908862/ https://www.ncbi.nlm.nih.gov/pubmed/35284017 http://dx.doi.org/10.1183/20734735.0148-2021 |
| _version_ | 1784665967422341120 |
|---|---|
| author | Everard, Mark L. |
| author_facet | Everard, Mark L. |
| author_sort | Everard, Mark L. |
| collection | PubMed |
| description | While advocating for addressing “treatable traits” is admirable in that it reminds clinicians to consider the patient and not the disease, the use of this idea to promote dangerous changes in practice should be challenged. https://bit.ly/30VkP8Q |
| format | Online Article Text |
| id | pubmed-8908862 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89088622022-03-11 Challenging the paradigm Everard, Mark L. Breathe (Sheff) Correspondence While advocating for addressing “treatable traits” is admirable in that it reminds clinicians to consider the patient and not the disease, the use of this idea to promote dangerous changes in practice should be challenged. https://bit.ly/30VkP8Q European Respiratory Society 2022-03 2022-03-08 /pmc/articles/PMC8908862/ /pubmed/35284017 http://dx.doi.org/10.1183/20734735.0148-2021 Text en Copyright ©ERS 2022 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Correspondence Everard, Mark L. Challenging the paradigm |
| title | Challenging the paradigm |
| title_full | Challenging the paradigm |
| title_fullStr | Challenging the paradigm |
| title_full_unstemmed | Challenging the paradigm |
| title_short | Challenging the paradigm |
| title_sort | challenging the paradigm |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908862/ https://www.ncbi.nlm.nih.gov/pubmed/35284017 http://dx.doi.org/10.1183/20734735.0148-2021 |
| work_keys_str_mv | AT everardmarkl challengingtheparadigm |